Connect Biopharma Holdings (CNTB) Current Assets (2020 - 2026)
Connect Biopharma Holdings (CNTB) posted Current Assets of $55.0 million for Q1 2026, up 8.03% sequentially from $50.9 million in Q4 2025, and down 37.3% YoY from $87.8 million in Q1 2025.
Connect Biopharma Holdings (CNTB) Current Assets (2020 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Current Assets for 7 years, with the latest figure at $55.0 million in Q1 2026.
- Quarterly Current Assets fell 37.3% year-over-year to $55.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.0 million (down 37.3% YoY) and the FY2025 annual result came in at $50.9 million, down 47.47% from the prior year.
- Current Assets improved to $55.0 million in Q1 2026 per CNTB's latest filing, from $50.9 million in the prior quarter.
- Over five years, Current Assets peaked at $197.8 million in Q2 2022 and troughed at $50.9 million in Q4 2025.
- A 5-year average of $105.3 million and a median of $97.0 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets decreased 16.12% in 2024, then sank 47.47% in 2025.
- Over 5 years, Current Assets stood at $152.5 million in 2022, then declined by 19.66% to $122.6 million in 2023, then slipped by 20.88% to $97.0 million in 2024, then tumbled by 47.47% to $50.9 million in 2025, then grew by 8.03% to $55.0 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $55.0 million, $50.9 million, and $62.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 38.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.62 Mn |
| Mar 31, 2026 | 55.02 Mn |
| Dec 31, 2025 | 50.93 Mn |
| Sep 30, 2025 | 62.60 Mn |
| Jun 30, 2025 | 77.76 Mn |
| Mar 31, 2025 | 87.76 Mn |
| Dec 31, 2024 | 96.96 Mn |
| Jun 30, 2024 | 115.90 Mn |
| Dec 31, 2023 | 122.55 Mn |
| Jun 30, 2023 | 138.17 Mn |
| Dec 31, 2022 | 152.55 Mn |
| Jun 30, 2022 | 197.76 Mn |
| Dec 31, 2021 | 274.36 Mn |
| Dec 31, 2020 | 159.46 Mn |